The hiring of a former top FDA official amplifies "revolving door" criticism at the worst possible time, STAT's Adam ...

As the second Trump administration settles in, the U.S.' top pharmaceutical trade group is drafting its ambitions for the ...

President Donald Trump reportedly issued a stringent warning to pharmaceutical companies, advising them to repatriate their ...

Greek-American Pfizer CEO Dr Albert Bourla faced an unwelcoming reception at the White House during an event celebrating ...

The future of the CDC’s vaccine advisory committee seems uncertain: A scheduled February meeting for the ACIP, which advises ...

President Trump also refused to promise pharma execs that he would hamstring the IRA’s drug negotiation program.

A study by KFF found that one in four Republican parents now say they've skipped or delayed some childhood vaccines as of January 2025.

Pfizer has signed a deal with Summit Therapeutics to assess the efficacy of Summit’s ivonescimab in combination with several ...

Pfizer Inc. (NYSE: PFE) invites investors and the general public to listen to a webcast of a discussion with Albert Bourla, ...

Pfizer is vulnerable to the possibility that President Donald Trump will place tariffs on the European Union, where the ...